Literature DB >> 22755505

Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.

Dirk Mueller1, Ingo Klette, Richard P Baum, M Gottschaldt, Michael K Schultz, Wouter A P Breeman.   

Abstract

A simple sodium chloride (NaCl) based (68)Ga eluate concentration and labeling method that enables rapid, high-efficiency labeling of DOTA conjugated peptides in high radiochemical purity is described. The method utilizes relatively few reagents and comprises minimal procedural steps. It is particularly well-suited for routine automated synthesis of clinical radiopharmaceuticals. For the (68)Ga generator eluate concentration step, commercially available cation-exchange cartridges and (68)Ga generators were used. The (68)Ga generator eluate was collected by use of a strong cation exchange cartridge. 98% of the total activity of (68)Ga was then eluted from the cation exchange cartridge with 0.5 mL of 5 M NaCl solution containing a small amount of 5.5 M HCl. After buffering with ammonium acetate, the eluate was used directly for radiolabeling of DOTATOC and DOTATATE. The (68)Ga-labeled peptides were obtained in higher radiochemical purity compared to other commonly used procedures, with radiochemical yields greater than 80%. The presence of (68)Ge could not be detected in the final product. The new method obviates the need for organic solvents, which eliminates the required quality control of the final product by gas chromatography, thereby reducing postsynthesis analytical effort significantly. The (68)Ga-labeled products were used directly, with no subsequent purification steps, such as solid-phase extraction. The NaCl method was further evaluated using an automated fluid handling system and it routinely facilitates radiochemical yields in excess of 65% in less than 15 min, with radiochemical purity consistently greater than 99% for the preparation of (68)Ga-DOTATOC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22755505     DOI: 10.1021/bc300103t

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  33 in total

1.  Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.

Authors:  Yusuf Menda; Thomas M O'Dorisio; James R Howe; Michael Schultz; Joseph S Dillon; David Dick; G Leonard Watkins; Timothy Ginader; David L Bushnell; John J Sunderland; Gideon K D Zamba; Michael Graham; M Sue O'Dorisio
Journal:  J Nucl Med       Date:  2017-02-02       Impact factor: 10.057

2.  (68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

Authors:  Francesco Ceci; Christian Uprimny; Bernhard Nilica; Llanos Geraldo; Dorota Kendler; Alexander Kroiss; Jasmin Bektic; Wolfgang Horninger; Peter Lukas; Clemens Decristoforo; Paolo Castellucci; Stefano Fanti; Irene J Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-15       Impact factor: 9.236

Review 3.  68Ga-DOTA and analogs: Current status and future perspectives.

Authors:  Krzysztof Kilian
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-19

4.  Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue.

Authors:  Julia Greiser; Tobias Niksch; Wolfgang Weigand; Martin Freesmeyer
Journal:  J Vis Exp       Date:  2016-08-17       Impact factor: 1.355

5.  A new automated NaCl based robust method for routine production of gallium-68 labeled peptides.

Authors:  Michael K Schultz; Dirk Mueller; Richard P Baum; G Leonard Watkins; Wouter A P Breeman
Journal:  Appl Radiat Isot       Date:  2012-08-31       Impact factor: 1.513

6.  68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.

Authors:  Christian Uprimny; Alexander Stephan Kroiss; Clemens Decristoforo; Josef Fritz; Elisabeth von Guggenberg; Dorota Kendler; Lorenza Scarpa; Gianpaolo di Santo; Llanos Geraldo Roig; Johanna Maffey-Steffan; Wolfgang Horninger; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-31       Impact factor: 9.236

7.  First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.

Authors:  Richard P Baum; Harshad R Kulkarni; Dirk Müller; Stanley Satz; Narasimhan Danthi; Young-Seung Kim; Martin W Brechbiel
Journal:  Cancer Biother Radiopharm       Date:  2015-05       Impact factor: 3.099

8.  Optimization of a Labeling and Kit Preparation Method for Ga-68 Labeled DOTATATE, Using Cation Exchange Resin Purified Ga-68 Eluates Obtained from a Tin Dioxide 68Ge/68Ga Generator.

Authors:  Deidré Prince; Daniel Rossouw; Sietske Rubow
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

9.  Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.

Authors:  Christian Uprimny; Alexander Stephan Kroiss; Clemens Decristoforo; Josef Fritz; Boris Warwitz; Lorenza Scarpa; Llanos Geraldo Roig; Dorota Kendler; Elisabeth von Guggenberg; Jasmin Bektic; Wolfgang Horninger; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-29       Impact factor: 9.236

10.  Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.

Authors:  Yusuf Menda; Laura L Boles Ponto; Michael K Schultz; Gideon K D Zamba; G Leonard Watkins; David L Bushnell; Mark T Madsen; John J Sunderland; Michael M Graham; Thomas M O'Dorisio; M Sue O'Dorisio
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.